rs1805087, MTR

N. diseases: 135
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.050 GeneticVariation BEFREE Thus, the common polymorphism (rs1805087) of <i>METH</i> may be associated with increased prostate cancer risk. 30337500 2018
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.050 GeneticVariation BEFREE Human methionine synthase A2756G polymorphism increases susceptibility to prostate cancer. 30064122 2018
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.050 GeneticVariation BEFREE In a meta-analysis of folate-pathway polymorphisms, MTR 2756A > G (eight studies, OR = 1.06; 95% CI 1.00, 1.12; P = 0.06) and SHMT1 1420C > T (two studies, OR = 1.11; 95% CI 1.00, 1.22; P = 0.05) were positively associated with prostate cancer risk. 23724740 2013
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.050 GeneticVariation BEFREE Genetic polymorphisms in MTHFR (C677T, A1298C), MTR (A2756G) and MTRR (A66G) genes associated with pathological characteristics of prostate cancer in the Ecuadorian population. 23459165 2013
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.050 GeneticVariation BEFREE Vitamin B(12), holo-haptocorrin, and the folate-pathway single-nucleotide polymorphisms MTR 2756A>G and SHMT1 1420C>T have been associated with an increased risk of prostate cancer. 20852008 2010